Koers Titan Medical Inc. Toronto S.E.
Aandelen
CA88830X1087
Geavanceerde medische apparatuur & technologie
Omzet 2022 | - | Omzet 2023 | 17,63 24,26 16,51 | Marktkapitalisatie | 6,87 mln. 9,45 mln. 6,43 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -42 mln. -57,79 mln. -39,33 mln. | Nettowinst (verlies) 2023 | 6 mln. 8,26 mln. 5,62 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 1,58 mln. 2,17 mln. 1,48 mln. | Nettoliquiditeiten 2023 | 6,27 mln. 8,62 mln. 5,87 mln. | EV/omzet 2023 | 34.203 x |
K/w-verhouding 2022 |
-1,74
x | K/w-verhouding 2023 |
1,01
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99,58% |
Recentste transcriptie over Titan Medical Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Cataford
CEO | Chief Executive Officer | 60 | 30-09-20 |
Chien Huang
DFI | Director of Finance/CFO | - | - |
Cary Vance
BRD | Director/Board Member | 58 | 30-09-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Cataford
CEO | Chief Executive Officer | 60 | 30-09-20 |
Director/Board Member | 67 | 30-09-20 | |
Cary Vance
BRD | Director/Board Member | 58 | 30-09-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,15% | 217 mld. | |
+6,60% | 183 mld. | |
+9,86% | 131 mld. | |
+24,32% | 106 mld. | |
-0,95% | 62,16 mld. | |
+11,04% | 51,02 mld. | |
+4,81% | 50,89 mld. | |
-1,43% | 40,16 mld. | |
+24,40% | 31,44 mld. |